| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Oct 30, 2026 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$329.00
Est. +94%
|
$169.42 | $180.61 |
Pending
|
$161.08
-4.9%
|
| Oct 15, 2026 |
Arrowhead Pharmaceuticals Inc.
ARWR
|
BUY |
$109.00
Est. +87%
|
$58.37 | $61.99 |
Pending
|
$61.65
+5.6%
|
| Oct 15, 2026 |
PTC Therapeutics Inc
PTCT
|
BUY |
$90.00
Est. +51%
|
$59.67 | $70.11 |
Pending
|
$68.97
+15.6%
|
| Oct 15, 2026 |
Alnylam Pharmaceuticals Inc
ALNY
|
BUY |
$354.00
Est. +58%
|
$224.47 | $238.96 |
Pending
|
$161.08
-28.2%
|